Bharat Seats Approves FY26 Results, Recommends 75% Dividend, Approves ₹86.61 Cr Capex
Bharat Seats Limited announced its audited financial results for FY26. The company reported revenue of ₹1,95,095.14 lakh and profit before tax of ₹5,760.26 lakh for the year. The Board recommended a 75% dividend (₹1.50 per share) and approved a ₹86.61 crore capex for Maruti Suzuki programs. Mr. Rishabh Relan's re-appointment as Whole-time Director was recommended.
The approval of annual financial results, a dividend recommendation, and a substantial capital expenditure are material events for the company.
The company reported positive financial results, recommended a dividend, and approved a significant capital expenditure, indicating growth and shareholder returns.
Bharat Seats Limited's Board of Directors, in a meeting held on May 6, 2026, approved the audited financial results for the quarter and financial year ended March 31, 2026. The company reported revenue from operations of ₹57,427.78 lakhs for the quarter and ₹1,95,095.14 lakhs for the year. Profit before tax for the quarter stood at ₹1,851.71 lakhs, and for the year at ₹5,760.26 lakhs. The Board also took note of the unmodified audit report from M/s S.R. Batliboi & Co., LLP.
Key decisions from the meeting include the approval of a capital expenditure of approximately ₹86.61 crores for new Maruti Suzuki India Limited programs at the Kharkhoda and Gujarat Navyani plants. The Board has recommended a dividend of 75% (₹1.50 per equity share of ₹2 each) for the financial year ended March 31, 2026, subject to shareholder approval. The record date for this dividend is set as July 17, 2026.
Furthermore, the Board approved the draft notice for the 39th Annual General Meeting (AGM), scheduled to be held on Friday, July 24, 2026. They also approved the draft Directors' Report, Management Discussion and Analysis, and Corporate Governance Report for the year ended March 31, 2026. The Board has recommended the re-appointment of Mr. Rishabh Relan as Whole-time Director for a term of three years from February 4, 2027, to February 3, 2030, pending shareholder approval. The company also approved the revised CSR Policy.
What to do with a filing like this
Bharat Seats Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bharat Seats Limited. Read the original for the full detail.